Why Foreign Medical Device Makers Need Indian Authorized Agent (IAA)

If you are a foreign manufacturer wanting to sell your medical devices in India, you cannot do it directly unless you have a subsidiary or IAA. Indian law requires you to appoint an Authorized Indian Representative, also called an authorized agent, to hold your import license and stand as your local point of accountability. Getting this relationship right is one of the first and most important steps in India market entry. 

If you are a foreign manufacturer planning to sell your medical devices in India, you cannot do so directly unless you have an Indian subsidiary or appoint an Authorized Indian Representative (AIR). Under the Medical Devices Rules, 2017, foreign manufacturers are required to appoint an AIR, sometimes also referred to as an authorized agent, to act on their behalf before the Central Drugs Standard Control Organization (CDSCO). The AIR is responsible for obtaining and maintaining the import license, serving as the local point of regulatory accountability, and ensuring ongoing compliance with Indian regulatory requirements. The representative also acts as the primary point of contact with the CDSCO, coordinates responses to regulatory queries, supports post-market surveillance and vigilance activities, and assists with license amendments, renewals, and other regulatory obligations throughout the product’s lifecycle. Without a duly appointed AIR, a foreign manufacturer cannot legally obtain an import license or place medical devices on the Indian market. Establishing this relationship correctly is therefore one of the first and most important steps for a successful entry into the Indian medical device market.

What an Authorized Indian Representative does

An Indian Authorized Representative (IAA) is an India-based entity that holds the applicable CDSCO import license on behalf of the overseas manufacturer and acts as its legal representative before the Central Drugs Standard Control Organization (CDSCO). The IAA is responsible not only for obtaining and maintaining the import license but also for managing regulatory communication with the authority, coordinating responses to regulatory queries and inspections, maintaining regulatory documentation and license records, supporting license amendments and renewals, and ensuring compliance with the Medical Devices Rules, 2017. In addition, the IAA plays a key role in post-market activities by coordinating complaint handling, adverse event reporting, recalls, Field Safety Corrective Actions (FSCAs), Field Safety Notices (FSNs), and other vigilance requirements, ensuring that the medical device continues to comply with Indian regulatory requirements throughout its lifecycle. 

The 2025 change you must know

Here is the update that catches many companies by surprise. A CDSCO FAQ addendum issued in November 2025 confirmed that when a company changes its Authorized Indian Representative, a fresh import license is required. There is currently no transfer mechanism that lets you simply move an existing license to a new representative. That means switching partners is not a quick administrative swap. It restarts part of the licensing process, which can affect your timelines and your continuity of supply.

What this means in practice

• Choose your representative carefully from the start, because changing later means re-applying for the import license and its administrative and regulatory burden. 
• Build the cost and time of a fresh license into any plan to change representatives.
• Make sure your agreement clearly assigns responsibility for licenses, vigilance and record keeping. 
• Confirm that the representative has the regulatory capacity to handle CDSCO queries promptly.

Picking the right partner

Because the representative carries legal responsibility for your devices in India, look for more than a mailbox. You want a partner with genuine regulatory depth, experience across device classes, and the ability to manage submissions through the SUGAM portal. The right representative does not just satisfy a legal box. They actively protect your market access and react quickly when CDSCO has questions.

Why your distributor should not be your IAA

It is tempting to hand the Authorized Indian Representative role to your Indian distributor, since they are already in the market and eager to help. In practice, this creates serious risks:

1. Switching distributors becomes far more painful. Because changing your IAA now triggers a fresh import license, tying the IAA role to a distributor means every commercial change to your distribution arrangement can disrupt your regulatory standing and your continuity of supply. 
2. Conflict of interest. A distributor’s core incentive is sales and margin, not regulatory rigour. Vigilance reporting, complaint handling, and honest communication with CDSCO can conflict with a distributor’s commercial interests, especially when a report might slow sales or expose a product issue and some of the tenders you may plan to participate. 
3. You can be locked into one commercial partner. If your IAA and distributor are the same entity, you cannot easily appoint additional or alternative distributors without untangling the regulatory relationship, which limits your ability to expand or renegotiate. 
4. Regulatory capability is not their specialty. Many distributors are strong at logistics and selling but lack deep CDSCO and SUGAM portal experience. Regulatory missteps then fall back on your market access. 
5. Data and record ownership risk. The IAA holds records that prove your device is legally on the market. If those sit with a distributor you later leave, recovering or reconstructing them can be difficult.

Keeping the IAA role with an independent regulatory partner, separate from your commercial distribution, protects your license, keeps your options open, and removes the conflict of interest. 

How NexorTest helps

NexorTest acts as an Indian Authorized Representative (IAA) and supports foreign manufacturers through CDSCO registration, import licensing and ongoing compliance. With the new fresh-license rule in play, having a stable, experienced representative from the outset is more valuable than ever. We help you enter the Indian market cleanly and stay compliant as the rules evolve.